Tag Archives: Keystone Bank

CORRECTED-(OFFICIAL)-Nigeria appoints Citigroup, Vetiva to manage sale of bank

Thu Jul 18, 2013 9:37am EDT
(Corrects to say AMCON appoints Citigroup, Vetiva to sell Enterprise Bank not all three nationalised banks)LAGOS, July 18 (Reuters) – The Asset Management Company of Nigeria, which holds non-performing assets of troubled banks, said it had named Citigroup and Africa-focused investment bank Vetiva

Read More 0 Comments

NBCUniversal OKs $6.4M Settlement With Unpaid Interns

NBCUniversal has agreed to settle claims brought by former interns who claimed they were required to work without pay on shows such as “Saturday Night Live” in violation of labor laws.
If approved, the $6.4 million settlement will pay the lead plaintiff, former “Saturday Night Live” intern Monet Eliastam,

NBCUniversal OKs $6.4M Settlement With Unpaid Interns

NBCUniversal has agreed to settle claims brought by former interns who claimed they were required to work without pay on shows such as “Saturday Night Live” in violation of labor laws.
If approved, the $6.4 million settlement will pay the lead plaintiff, former “Saturday Night Live” intern Monet Eliastam,

Settlement: Verizon Unpaid Wages Class Actions Reach $15M Settlement

October 22 2014Los Angeles, CA: A $15 million settlement has received preliminary approval ending a wage and hour class action lawsuit brought against Verizon California Inc. In the California labor law class action, the plaintiffs claimed Verizon issued inaccurate wage statements that omitted crucial information making it impossible for

CORRECTED-U.S. SEC slams tycoon Wyly’s bankruptcy budget as ‘staggering’

Thu Oct 23, 2014 10:01am EDT

(Corrects SEC lawyer’s name from Dunn to Dodd in third
paragraph)
By Joseph Ax and Nate RaymondOct 22 (Reuters) – Texas tycoon Sam Wyly, who filed for
bankruptcy this week, is trying to exhaust his fortune through
exorbitant spending to impede the U.S.

Investigation: Blood Thinner Brilinta Under Investigation

October 22 2014Los Angeles, CA: AstraZeneca is facing a lawsuit brought by scientists who allege
consumer fraud on the part of the pharmaceutical company, specifically that it fudged the data in its late stage study of the blood thinner Brilinta. The allegations have led to a federal probe into